menu
    • menu

    Company profile for Nuvation Bio

    NEW Drugs in Dev: 7
    With Fermion, start the journey of your innovative API.

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-03-23

    Virtual Booth

    Contact Supplier

    Transo-Pharm GmbH works globally to supply Active Pharmaceutical Ingredients adhering to the highest quality & GMP standards.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2026-03-23

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    Nuvation Bio, is a privately-held biopharmaceutical company currently operating in stealth mode that is focused on the development of next generation therapies that will target the foremost unmet needs in oncology. Nuvation Bio's proprietary portfolio includes seven novel and mechanistically distinct oncology programs, each with multiple drug development candidates. Nuvation Bio was founded in 2018 by industry veteran David Hu...
    Nuvation Bio, is a privately-held biopharmaceutical company currently operating in stealth mode that is focused on the development of next generation therapies that will target the foremost unmet needs in oncology. Nuvation Bio's proprietary portfolio includes seven novel and mechanistically distinct oncology programs, each with multiple drug development candidates. Nuvation Bio was founded in 2018 by industry veteran David Hung, M.D., who previously founded and served as President and Chief Executive Officer of Medivation. Nuvation Bio has offices in New York and San Francisco.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    Nuvation BioUnited_States_of_America Flag
    Country
    Country
    U.S.A
    Address
    Address
    1500 Broadway Suite 1401 New York, NY 10036
    Telephone
    Telephone
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.nuvationbio.com/
    Linkedin
    Linkedin
    https://in.linkedin.com/company/nuvationbio
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    Default Event

    CGT Asia

    Not Confirmed

    envelop Contact Supplier

    CGT Asia

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Eisai, Nuvation Bio Seek Ema Approval For Taletrectinib In Cancer
    Eisai, Nuvation Bio Seek Ema Approval For Taletrectinib In Cancer

    26 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/eisai-and-nuvation-bio-announce-marketing-authorisation-application-for-taletrectinib-for-the-treatment-of-advanced-ros1-positive-non-small-cell-lung-cancer-validated-by-the-european-medicines-agency-302726651.html

    PR NEWSWIRE
    26 Mar 2026
    Share Share
    Nuvation Bio To Present IBTROZI Data In Ros1+ NSCLC Patients
    Nuvation Bio To Present IBTROZI Data In Ros1+ NSCLC Patients

    18 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nuvation-bio-to-present-pivotal-ibtrozi-taletrectinib-data-in-tki-naive-and-tki-pretreated-patients-with-advanced-ros1-positive-non-small-cell-lung-cancer-at-aacr-2026-302716514.html

    PR NEWSWIRE
    18 Mar 2026
    Share Share
    Nuvation Bio Reveals 2025 Financials And Business Update
    Nuvation Bio Reveals 2025 Financials And Business Update

    02 Mar 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nuvation-bio-reports-fourth-quarter-and-full-year-2025-financial-results-and-provides-business-update-302701317.html

    PR NEWSWIRE
    02 Mar 2026
    Share Share
    Nuvation Bio To Participate In Upcoming Investor Conferences
    Nuvation Bio To Participate In Upcoming Investor Conferences

    25 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nuvation-bio-to-participate-in-upcoming-investor-conferences-302697197.html

    PR NEWSWIRE
    25 Feb 2026
    Share Share
    Nuvation Bio To Share 2025 Financials And Business Update
    Nuvation Bio To Share 2025 Financials And Business Update

    17 Feb 2026

    // PR NEWSWIRE

    https://www.prnewswire.com/news-releases/nuvation-bio-to-report-fourth-quarter-and-full-year-2025-financial-results-and-provide-business-update-on-march-2-2026-302688141.html

    PR NEWSWIRE
    17 Feb 2026
    Share Share
    Nuvation Bio Launches Global Phase 3 Trial For Safusidenib
    Nuvation Bio Launches Global Phase 3 Trial For Safusidenib

    09 Feb 2026

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20260204350848/en/Nuvation-Bio-Announces-Pivotal-Global-Phase-3-SIGMA-Trial-G203-for-Safusidenib-in-IDH1-Mutant-Glioma

    BUSINESSWIRE
    09 Feb 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search